Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07519226
NA

Effectiveness and Safety of Penehyclidine Hydrochloride for Improving Microcirculatory Dysfunction in Critically Ill Children

Sponsor: Lihua Wen

View on ClinicalTrials.gov

Summary

This prospective randomized controlled trial was designed to evaluate whether the M1/M3-selective antagonist penehyclidine hydrochloride could more effectively reverse pediatric microcirculatory dysfunction than traditional atropine, particularly when macrohemodynamics appear normalized.

Official title: Effectiveness and Safety of Penehyclidine Hydrochloride for Improving Microcirculatory Dysfunction in Critically Ill Children: A Single-Center, Prospective, Randomized Controlled Trial

Key Details

Gender

All

Age Range

28 Days - 18 Years

Study Type

INTERVENTIONAL

Enrollment

98

Start Date

2024-05-08

Completion Date

2026-03-01

Last Updated

2026-04-09

Healthy Volunteers

No

Conditions

Interventions

DRUG

atropine control group

atropine control group

DRUG

penehyclidine hydrochloride group

penehyclidine hydrochloride

Locations (1)

Guangzhou Women and Children's Medical Center

Guangzhou, Guangdong, China